Rani Therapeutics Holdings Inc. (NASDAQ: RANI)
$4.01
+0.0200 ( +0.50% ) 189.8K
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads up to 200 microlitre in liquid form with high bioavailability.
Market Data
Open
$4.01
Previous close
$3.99
Volume
189.8K
Market cap
$103.90M
Day range
$3.89 - $4.19
52 week range
$1.82 - $8.75
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Dec 01, 2023 |
4 | Insider transactions | 1 | Nov 21, 2023 |
4 | Insider transactions | 1 | Nov 20, 2023 |
4 | Insider transactions | 1 | Nov 09, 2023 |
10-q | Quarterly Reports | 69 | Nov 08, 2023 |
8-k | 8K-related | 16 | Nov 08, 2023 |
8-k | 8K-related | 14 | Nov 01, 2023 |
8-k | 8K-related | 14 | Oct 25, 2023 |
8-k | 8K-related | 53 | Sep 07, 2023 |
10-q | Quarterly Reports | 68 | Aug 11, 2023 |